You are here: Home / Our people / Our academics / Dr Stephen Assinder 

Publications list for Dr Stephen Assinder

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007

2013

   
  • Dixon, K., Lui, G., Kovacevic, Z., Zhang, D., Yao, M., Chen, Z., Dong, Q., Assinder, S., Richardson, D. (2013), Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells. British Journal of Cancer. 108(2), 409-419. [Abstract]

2012

   
Back to Top
  • Bower, N., Garcia de la Serrana, D., Cole, N., Hollway, G., Lee, H., Assinder, S., Johnston, I. (2012), STAC3 is required for myotube formation and myogenic differentiation in vertebrate skeletal muscle. Journal of Biological Chemistry. 287, 43936-43949. [Abstract]

2011

   
Back to Top
  • Assinder, S., Cole, N. (2011), Does TGF-β induced formation of actin stress fibres reinforce Smad dependent TGF-β signalling in the prostate?. Medical hypotheses. 76(6), 802-4. [Abstract]
  • Assinder, S. (2011), TAGLN (transgelin). Atlas of Genetics and Cytogenetics in Oncology and Haematology. 15(6), 477-479.

2010

   
Back to Top
  • Assinder, S., Au, E., Dong, Q., Winnick, C. (2010), A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer. Molecular carcinogenesis. 49(6), 525-31. [Abstract]
  • Tom, N., Assinder, S. (2010), Oxytocin in health and disease. The international journal of biochemistry & cell biology. 42(2), 202-5. [Abstract]
  • Prasad, P., Stanton, J., Assinder, S. (2010), Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer. Cell and tissue research. 339(2), 337-47. [Abstract]
  • Tom, N., Assinder, S. (2010), Oxytocin: Recent developments. Biomolecular Concepts. 1(5-6), 367-380.

2009

   
Back to Top
  • Assinder, S., Stanton, J., Prasad, P. (2009), Transgelin: An actin-binding protein and tumour suppressor. The international journal of biochemistry & cell biology. 41(0), 482-6. [Abstract]
  • Assinder, S., Dong, Q., Mangs, H., Richardson, D. (2009), Pharmacological Targeting of the Integrated AKT, PTEN and TGF-{beta} Pathways in Prostate Cancer. Molecular pharmacology. 75(3), 429-36. [Abstract]
  • Assinder, S., Dong, Q., Kovacevic, Z., Richardson, D. (2009), The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer. Biochemical Journal. 417(2), 411-421. [Abstract]
  • Assinder, S. (2009), Oxytocin in the Pathophysiology of Prostate Cancer. In: Handbook of Oxytocin Research: Synthesis, Storage and Release, Actions and Drug Forms. (pp.155-170).United Kingdom: Nova Publishers.

2008

   
Back to Top
  • Assinder, S. (2008), Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells. The Prostate. 68, 115-21. [Abstract]
  • Nicholson, H., Assinder, S. (2008), Male gametogenesis. In: Textbook of Assisted Reproduction for Scientists in Reproductive Technology. (pp.3-30).Australia: VIVID Publishing.

2007

   
Back to Top
  • Whittington, K., Connors, B., King, K., Assinder, S., Hogarth, K., Nicholson, H. (2007), The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. The Prostate. 67(10), 1132-1142. [Abstract]
  • Assinder, S., Davis, R., Fenwick, M., Glover, A. (2007), Adult-only exposure of male rats to a diet of high phytoestrogen content increases apoptosis of meiotic and post-meiotic germ cells. Reproduction. 133(1), 11-19. [Abstract]